InvestSMART

Imugene Limited (ASX: IMU) - Announcements

Current share price for IMU : $0.082 0.001 (1.20%)+

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$40 Release of Shares from Voluntary Escrow 24 Jan 2025 6:54PM $0.038 $0.082 risen by 115.79%
$40 Cleansing Notice 24 Jan 2025 6:32PM $0.038 $0.082 risen by 115.79%
$40 Notification regarding unquoted securities - IMU 24 Jan 2025 5:05PM $0.038 $0.082 risen by 115.79%
$40 Results of Meeting 22 Jan 2025 1:39PM $0.039 $0.082 risen by 110.26%
$40 Imugene EGM Presentation 22 Jan 2025 8:57AM $0.040 $0.082 risen by 105%
$40 Application for quotation of securities - IMU 10 Jan 2025 4:58PM $0.043 $0.082 risen by 90.70%
$40 Imugene Receives $11.7m R&D Tax Refund 10 Jan 2025 1:31PM $0.043 $0.082 risen by 90.70%
$40 First Australian Patient Dosed in Phase 1b azer-cel Trial 3 Jan 2025 8:34AM $0.039 $0.082 risen by 110.26%
$40 Proposed issue of securities - IMU 24 Dec 2024 8:38AM $0.037 $0.082 risen by 121.62%
$40 Notice of Extraordinary General Meeting/Proxy Form 23 Dec 2024 6:25PM $0.037 $0.082 risen by 121.62%
$40 Issuance of Convertible Notes & Warrants for up to $46m 23 Dec 2024 5:29PM $0.037 $0.082 risen by 121.62%
$40 Azer-cel Accepted for Presentation at ASTCT Tandem Meetings 20 Dec 2024 1:20PM $0.036 $0.082 risen by 127.78%
$40 Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund 19 Dec 2024 8:54AM $0.038 $0.082 risen by 115.79%
$40 Updated Appendix 3Z 20 Nov 2024 6:25PM $0.040 $0.082 risen by 105%
$40 Final Director's Interest Notice 20 Nov 2024 5:13PM $0.040 $0.082 risen by 105%
$40 Director Resignation 15 Nov 2024 8:23AM $0.044 $0.082 risen by 86.36%
$40 Imugene 2024 AGM Results 14 Nov 2024 1:59PM $0.044 $0.082 risen by 86.36%
$40 Imugene AGM Presentation 14 Nov 2024 8:24AM $0.046 $0.082 risen by 78.26%
$40 onCARlytics Trial Doses First Patient in IT Combination Arm 11 Nov 2024 9:03AM $0.046 $0.082 risen by 78.26%
$40 Imugene Opens First Australian Site for azer-cel Trial 8 Nov 2024 10:08AM $0.045 $0.082 risen by 82.22%
$40 Complete Response in MAST Study Maintained Over Two Years 5 Nov 2024 9:04AM $0.044 $0.082 risen by 86.36%
$40 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 9:10AM $0.047 $0.082 risen by 74.47%
$40 Notification regarding unquoted securities - IMU 14 Oct 2024 4:40PM $0.053 $0.082 risen by 54.72%
$40 Notification of cessation of securities - IMU 14 Oct 2024 4:37PM $0.053 $0.082 risen by 54.72%
$40 Application for quotation of securities - IMU 14 Oct 2024 4:36PM $0.053 $0.082 risen by 54.72%

176 - 200 of 1186 results

Page 8 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.